News Release Archives:

2006 | 2005 | 2004
2003 | 2002 | 2001
2000 | 1999 | 1998


Jaff named medical director of the MGH Vascular Center

BOSTON - September 24, 2007 - Michael R. Jaff, DO (below left), a national and international leader in the diagnosis and treatment of vascular disease, has been named the first full-time medical director of the Massachusetts General Hospital (MGH) Vascular Center. Over the past several years, he has been integral in creating and shaping the Vascular Center at Mass General West in Waltham, a distinctive collaboration of clinical specialties working together to deliver comprehensive care to patients with a wide range of vascular conditions. An assistant professor of Medicine at Harvard Medical School, Jaff also directs the Vascular Diagnostic Laboratory at the main MGH campus in Boston, and he is medical director of the Vascular Ultrasound Core Laboratory, one of the world's largest peripheral vascular clinical device research ultrasound laboratories.

"We are delighted that Dr. Jaff has agreed to lead our hospitalwide Vascular Center," says Peter L. Slavin, MD, MGH president. "He has the leadership, collaborative spirit and medical and scientific expertise to guide our current clinical and academic programs as well as oversee our efforts to introduce new technologies that will help address the complex challenges of vascular disease."

The MGH Vascular Center brings together specialists from seven clinical disciplines - cardiology/vascular medicine, vascular and endovascular surgery, vascular radiology, neurology, neurosurgery, cardiac surgery and nephrology - and is the only such multidisciplinary vascular center in the country. The center provides evaluation and treatment for the full range of vascular disorders including peripheral arterial disease, stroke and carotid artery disease, renal and mesenteric artery disease, deep vein thrombosis, aneurysms, arteriovenous malformations, and problems with wound healing and blood coagulation.

Jaff, whose research focus includes novel therapies for peripheral vascular disease as well as device and clinical trial development, is a past president of the Society for Vascular Medicine. He recently was the first ever to be designated a master of that society. He serves as treasurer and a member of the Board of Directors for the Intersocietal Commission for the Accreditation of Vascular Laboratories. In addition, he is a founder and board member of the American Board of Vascular Medicine; on the boards of the Vascular Disease Foundation and the Peripheral Arterial Disease Coalition; and on the editorial boards of journals including Circulation, Catheterization and Cardiovascular Interventions, Vascular Medicine, the Journal of Vascular Surgery and Annals of Internal Medicine.

A graduate of the Kirksville College of Osteopathic Medicine in Missouri, Jaff was a resident in internal medicine and chief resident at the Cleveland Clinic, where he also completed a fellowship in vascular medicine. He is a resident of Newton, Mass.

Massachusetts General Hospital, established in 1811, is the original and largest teaching hospital of Harvard Medical School. The MGH conducts the largest hospital-based research program in the United States, with an annual research budget of nearly $500 million and major research centers in AIDS, cardiovascular research, cancer, computational and integrative biology, cutaneous biology, human genetics, medical imaging, neurodegenerative disorders, regenerative medicine, systems biology, transplantation biology and photomedicine. MGH and Brigham and Women's Hospital are founding members of Partners HealthCare HealthCare System, a Boston-based integrated health care delivery system.

Media Contacts: Jennifer Gundersen, MGH Public Affairs

Physician Referral Service: 1-800-388-4644
Information about Clinical Trials